Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Government of Canada was posted on April 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Subscription to a Drug Pricing Intelligence Database

Closed
SN26002International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 519290
New
Federal
Serial Subscription Services
Solicitation # 480207
Brookhaven Science Associates, acting for Brookhaven National Laboratory and the Department of Energy, is soliciting a firm-fixed-price contract for comprehensive serial subscription services under solicitation 480207. The selected contractor will be responsible for the placement, renewal, and management of domestic and foreign serials and periodicals in electronic, print, and other available formats. Key services include account and financial management, invoicing, claims processing, and the provision of a web-based serials management system to ensure uninterrupted access to scientific and technical information. The contract features a base performance period from November 1, 2026, to October 31, 2027, with four optional extension years, potentially extending the agreement through October 31, 2031. The acquisition is categorized under NAICS 519290 and is structured as a small business set-aside. Award will be granted to the responsive and responsible offeror providing the lowest total price while meeting all technical requirements and qualifiers. Offerors must be registered in SAM.gov and provide specific documentation, including a sample title list with 2026 pricing, sample invoices, evidence of online renewal capabilities, and two professional references. Compliance requirements include adherence to BNL supplier quality assurance standards, specific packaging and marking guidelines, and the Service Contract Act wage determinations for New York. All formal quotations must be submitted via email to the designated contracts specialist by September 16, 2026.
Brookhaven National Labor -Doe Contractor

POSTED

about 15 hours ago

DEADLINE

in 7 days

AI Contract Overview

Show more

The Patented Medicine Prices Review Board (PMPRB) is procuring a subscription to a drug pricing intelligence database to support its mandate of monitoring international pharmaceutical pricing and reimbursement practices. The contract, identified by solicitation number SN26002 and valued at $67,733.00 USD excluding GST/HST, is a sole-source award justified under subsection 6(d) of the Government Contracts Regulations, as GlobalData is deemed the only provider capable of meeting all mandatory requirements. The scope requires continuous, real-time access to an integrated platform delivering comprehensive, structured, and regularly updated global data on drug pricing, reimbursement policies, therapeutic costs, and international reference pricing dynamics across more than 80 markets. Key deliverables include daily headline analyses, monthly bulletins and special reports, country-specific profiles, market access risk scores for at least 70 markets, an interactive IRP mapping tool, and a fully searchable drug database with over 20 years of historical pricing data in monthly time series, filterable across 22 fields. The platform must also include a therapeutic cost calculation tool capable of estimating treatment costs based on dosing, duration, and indications, along with data on approval timelines, health technology assessment bodies, and reimbursement decisions. The contractor must provide direct analyst support via phone and email, support up to 15 concurrent users, and enable standardized Excel exports of at least 3,000 rows. All data must be normalized for cross-country comparability, derived from official or contractual sources, and fully transparent in methodology. The contract term runs from award until March 31, 2027, with performance required to be fully operational within 30 days of award. The platform must be accessible remotely from Ottawa, Canada, with no physical delivery or packaging requirements. The government retains no ownership of the intellectual property developed under the contract, which remains with the contractor. Proposals must be submitted via email to the designated point of contact by April 27, 2026, with no formal page limits but full compliance with minimum technical specifications required for award consideration. No trade agreements apply, no socioeconomic set-asides are in effect, and no security clearances or key personnel certifications are mandated.

General Info

PMPRB seeks subscription for drug pricing intelligence platform to analyze global pharmaceutical data.

Agency

Government of Canada → Patented Medicine Prices Review BoardView Agency

NAICS

519290 - Web Search Portals and All Other Information ServicesView NAICS

Place of Performance

*Ottawa, CAN

Set-Aside

NONE

Documents

(2)

Préavis d’adjudication de contrat SN26002 - Abonnement base de données prix médicaments

PDFpresolicitation

ACAN SN26002 Subscription to Drug Pricing Intelligence Database

PDFadvance-contract-award-notice

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Patented Medicine Prices Review Board
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Patented Medicine Prices Review Board
View Agency Profile
Office AddressN/A
Contacts
Sylvie BeaudoinPoint of Contact

Full Description

Show more
The Patented Medicine Prices Review Board (PMPRB) gathers information on international pricing and reimbursement regimes/policies and trends to carry out its work. To perform these functions, the PMPRB needs to invest considerable resources both internally and externally to gather and analyze the best available information on global pricing and reimbursement of pharmaceuticals. The requirement is to provide access to an integrated platform and supporting services that deliver comprehensive, structured, and regularly updated international pricing and reimbursement information, analytics, and intelligence.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS